Literature DB >> 9495799

Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons.

B D Schlag1, J R Vondrasek, M Munir, A Kalandadze, O A Zelenaia, J D Rothstein, M B Robinson.   

Abstract

Sodium-dependent transport into astrocytes is critical for maintaining the extracellular concentrations of glutamate below toxic levels in the central nervous system. In this study, the expression of the glial glutamate transporters GLT-1 and GLAST was studied in primary cultures derived from cortical tissue. In primary astrocytes, GLAST protein levels were approximately one half of those observed in cortical tissue, but GLT-1 protein was present at very low levels compared with cortical tissue. Maintenance of these astrocytes in medium supplemented with dibutyryl-cAMP (dbcAMP) caused a dramatic change in cell morphology, increased GLT-1 and GLAST mRNA levels approximately 5-fold, increased GLAST protein approximately 2-fold, and increased GLT-1 protein >/=8-20-fold. These increases in protein expression were accompanied by 2-fold increases in the Vmax and Km values for Na+-dependent L-[3H]glutamate transport activity. Although GLT-1 is sensitive to inhibition by dihydrokainate in heterologous expression systems, no dihydrokainate sensitivity was observed in astrocyte cultures that expressed GLT-1. Biotinylation with a membrane-impermeant reagent, separation of the biotinylated/cell surface proteins, and subsequent Western blotting demonstrated that both GLT-1 and GLAST were present at the cell surface. Coculturing of astrocytes with neurons also induced expression of GLT-1, which colocalized with the glial specific marker, glial fibrillary acidic protein. Neurons induced a small increase in GLAST protein. Several studies were performed to examine the mechanism by which neurons regulate expression of the glial transporters. Three different protein kinase A (PKA) antagonists did not block the effect of neurons on glial expression of GLT-1 protein, but the addition of dbcAMP to mixed cultures of neurons and astrocytes did not cause GLT-1 protein to increase further. This suggests that neurons do not regulate GLT-1 by activation of PKA but that neurons and dbcAMP regulate GLT-1 protein through convergent pathways. As was observed with GLT-1, the increases in GLAST protein observed in cocultures were not blocked by PKA antagonists, but unlike GLT-1, the addition of dbcAMP to mixed cultures of neurons and astrocytes caused GLAST protein to increase approximately 2-fold. Neurons separated from astrocytes with a semipermeable membrane increased GLT-1 protein, indicating that the effect of neurons was mediated by a diffusible molecule. Treatment of cocultures with high concentrations of either N-methyl-D-aspartate or glutamate killed the neurons, caused GLT-1 protein to decrease, and caused GLAST protein to increase. These studies suggest that GLT-1 and GLAST protein are regulated independently in astrocyte cultures and that a diffusible molecule secreted by neurons induces expression of GLT-1 in astrocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9495799     DOI: 10.1124/mol.53.3.355

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  91 in total

Review 1.  Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission.

Authors:  Arne Schousboe
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

2.  Brain endothelial cells induce astrocytic expression of the glutamate transporter GLT-1 by a Notch-dependent mechanism.

Authors:  Meredith L Lee; Zila Martinez-Lozada; Elizabeth N Krizman; Michael B Robinson
Journal:  J Neurochem       Date:  2017-09-05       Impact factor: 5.372

3.  The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism.

Authors:  Deborah E Bauer; Joshua G Jackson; Elizabeth N Genda; Misty M Montoya; Marc Yudkoff; Michael B Robinson
Journal:  Neurochem Int       Date:  2012-01-28       Impact factor: 3.921

4.  The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.

Authors:  Mausam Ghosh; Meredith Lane; Elizabeth Krizman; Rita Sattler; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurochem       Date:  2015-11-24       Impact factor: 5.372

Review 5.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

6.  Regulation of glutamate transporters in astrocytes: evidence for a relationship between transporter expression and astrocytic phenotype.

Authors:  Chrissandra J Zagami; Ross D O'Shea; Chew L Lau; Surindar S Cheema; Philip M Beart
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

7.  Increased glutamate uptake and GLAST expression by cyclic AMP in retinal glial cells.

Authors:  Tsutomu Sakai; Takashi Yoshitoshi; Yukiko Nagai; Kenji Kitahara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-02       Impact factor: 3.117

8.  Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity.

Authors:  Jianzheng Zhou; Margaret L Sutherland
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

9.  Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.

Authors:  Logan C Meyer; Caitlin E Paisley; Esraa Mohamed; John W Bigbee; Tomasz Kordula; Hope Richard; Kabirullah Lutfy; Carmen Sato-Bigbee
Journal:  Glia       Date:  2017-09-14       Impact factor: 7.452

10.  Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2).

Authors:  Zao-zhong Su; Magdalena Leszczyniecka; Dong-chul Kang; Devanand Sarkar; Wei Chao; David J Volsky; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.